Hemoglobin Oxygen Therapeutics hbo2therapeutics.com


Public lists: Pharma Startups (4729)

Hemoglobin Oxygen Therapeutics has developed two hemoglobin-based products: Hemopure (Hemoglobin Glutamer 250) for human application and Oxyglobin (Hemoglobin Glutamer 200) for veterinary application.

Hemoglobin Oxygen Therapeutics has developed two hemoglobin-based products: Hemopure (Hemoglobin Glutamer 250) for human application and Oxyglobin (Hemoglobin Glutamer 200) for veterinary application.

Company (Alive / Active)

Phone: 267-382-0064

Fax:

674 Souder Road

Souderton, 18964
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Hemoglobin Oxygen Therapeutics $1.5M Apr 13, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Hemoglobin Oxygen Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Method of isolating cells from a tissue in a mammal Jan 31, 2013 May 23, 2017 Patent
Method of isolating cells from a tissue in a mammal May 23, 2017 Application